Leah Lawrence

Molecular subtype-based treatment can improve outcomes in patients with recurrent or metastatic triple-negative breast cancer, a phase 2 trial suggests.

Patients with HPV-related oropharyngeal cancer have lower overall survival rates if they are treated at community cancer centers rather than academic centers, data suggest.

Chemotherapy rechallenge provides a greater benefit than regorafenib as third-line treatment for metastatic colorectal cancer, data suggest.

Liso-cel is cost-effective as second-line therapy for diffuse large B-cell lymphoma, according to researchers.

Receiving immunosuppressive therapy before starting immune checkpoint inhibitor treatment may negatively affect survival outcomes in patients with advanced melanoma, new research suggests.

Bevacizumab, etoposide, and cisplatin given before whole-brain radiotherapy may help control brain metastases in patients with breast cancer.

The risk of adverse pregnancy outcomes among cancer survivors may vary by cancer type, a new study suggests.

Adding pembrolizumab to perioperative chemotherapy did not improve survival outcomes in patients with resectable gastric or GEJ cancer.

Black patients with prostate cancer report worse pain than their White peers, and more severe pain is associated with a higher risk of death, data suggest.

SBRT improved upon standard care in patients with oligoprogressive NSCLC but not in those with oligoprogressive breast cancer.